Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Viruses|March 13, 2019
Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice ModelsTouraj Aligholipour Farzani, Katalin Földes, Alireza Hanifehnezhad, et al.
BMC Health Services Research|March 27, 2020
A micro-elimination approach to addressing hepatitis C in TurkeyRamazan Idilman, Homie Razavi, Sarah Robbins-Scott, et al.
Heliyon|February 15, 2024
Concordance and generalization of an AI algorithm with real-world clinical data in the pre-omicron and omicron eraGulsen Yilmaz, Sevilay Sezer, Aliye Bastug, et al.
Clinical Chemistry and Laboratory Medicine|November 4, 2009
Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic feverYasemin Gulcan Kurt, Tuncer Cayci, Pinar Onguru, et al.
Japanese Journal of Infectious Diseases|December 27, 2005
Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCRMehmet Yapar, Hakan Aydogan, Alaaddin Pahsa, et al.
Bosnian Journal of Basic Medical Sciences|February 12, 2021
Predictive performance of CT for adverse outcomes among COVID-19 suspected patients: a two-center retrospective studyBegümhan Baysal, Mahmut Bilal Dogan, Mutlu Gulbay, et al.
The Journal of Infection|April 19, 2008
High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortalityPinar Onguru, Emin Ozgur Akgul, Esragul Akinci, et al.
International Immunopharmacology|September 12, 2020
Clinical and laboratory features of COVID-19: Predictors of severe prognosisAliye Bastug, Hurrem Bodur, Serpil Erdogan, et al.
The Journal of Infection|February 28, 2009
Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from TurkeyNazif Elaldi, Hurrem Bodur, Sibel Ascioglu, et al.
Journal of Infection in Developing Countries|December 16, 2014
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis BErtugrul Guclu, Nazan Tuna, Oguz Karabay, et al.
Pageof 6